Le Lézard
Classified in: Health
Subject: MRR

Worldwide Methylsulfonylmethane Industry to 2030 - by Application and Region

DUBLIN, Jan. 31, 2023 /PRNewswire/ -- The "Methylsulfonylmethane Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

The purpose of this strategic research study is to offer industry investors, company executives, and industry participants with in-depth insights to enable them make informed strategic decisions related to the opportunities in the methylsulfonylmethane market.

Methylsulfonylmethane (MSM) is a form of organic sulfur that is found in many different fruits, vegetables, grains, and animals. Methylsulfonylmethane is a product of dimethyl sulfoxide (DMSO) and is also known as DMSO2, methyl sulfone, and dimethyl sulfone.

On the basis of application, the global methylsulfonylmethane (MSM) market is segmented into food & beverage, pharmaceutical & dietary supplements, cosmetics & personal care, animal feed and other industries (agriculture, urban waste handling and etc.).

In 2021, pharmaceutical & dietary supplements accounted for the largest share of more than 55% of the total MSM market by volume. Ageing population, rising bone and joint health concerns and rising awareness regarding health concerns are the major factors contributing towards the market growth.

The global methylsulfonylmethane market is segmented by geography into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2021, North America was observed as the largest market for Methylsulfonylmethane. It contributed about more than 40% to the total demand of the methylsulfonylmethane during year 2021.

The methylsulfonylmethane market of Asia Pacific zone is predicted to register highest rate of growth during the projected period. This growth is majorly attributed to growing demand from synthetic lubricant and polyethylene industries, particularly from economies such as Japan, China and India.

Bergstrom Nutrition, Inc., Hubei Xingfa Chemicals Group Co., Ltd., Yueyang Xiangmao Medicines & Chemicals Co., Ltd., Makana Produktion und Vertrieb GmbH, Vita Flex Nutrition, ZhuZhou Hansen Chemical Co, Ltd., Panvo Organics Pvt. Ltd., Chaitanya Biologicals Pvt. Ltd, Tianjin Baofeng Chemical Co., Ltd and Hangzhou Dakang New Materials Co., Ltd. are few key manufacturers in methylsulfonylmethane market.

Key questions answered in this report

Key Topics Covered:

1. Preface

2. Executive Summary

3. Methylsulfonylmethane Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Methylsulfonylmethane Market Value, 2020-2030, (US$ Million)
3.3. Key Trends Analysis
3.4. Market Dynamics
3.4.1. Market Drivers
3.4.2. Market Restraints
3.4.3. Key Challenges
3.4.4. Key Opportunities
3.5. Impact Analysis of Drivers and Restraints
3.6. See-Saw Analysis
3.7. Attractive Investment Proposition
3.8. Porter's Five Force Model
3.9. PESTEL Analysis
3.10. Competitive Landscape
3.10.1. Market Positioning of Key Methylsulfonylmethane Market Vendors
3.10.2. Strategies Adopted by Methylsulfonylmethane Market Vendors

4. Methylsulfonylmethane Market: By Application, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Food & Beverage
4.3.2. Pharmaceutical & Dietary Supplements
4.3.3. Cosmetics & Personal Care
4.3.4. Animal Feed
4.3.5. Other Industries (Agriculture, Urban Waste Handling, etc.)

5. North America Methylsulfonylmethane Market, 2020-2030, USD (Million)

6. UK and European Union Methylsulfonylmethane Market, 2020-2030, USD (Million)

7. Asia Pacific Methylsulfonylmethane Market, 2020-2030, USD (Million)

8. Latin America Methylsulfonylmethane Market, 2020-2030, USD (Million)

9. Middle East and Africa Methylsulfonylmethane Market, 2020-2030, USD (Million)

10. Company Profile
10.1. Bergstrom Nutrition, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Portfolio
10.1.4. Strategic Initiatives
10.2. Hubei Xingfa Chemicals Group Co., Ltd.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Portfolio
10.2.4. Strategic Initiatives
10.3. Yueyang Xiangmao Medicines & Chemicals Co., Ltd.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Portfolio
10.3.4. Strategic Initiatives
10.4. Makana Produktion und Vertrieb GmbH
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Portfolio
10.4.4. Strategic Initiatives
10.5. Vita Flex Nutrition
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Portfolio
10.5.4. Strategic Initiatives
10.6. ZhuZhou Hansen Chemical Co, Ltd.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Portfolio
10.6.4. Strategic Initiatives
10.7. Panvo Organics Pvt. Ltd.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Portfolio
10.7.4. Strategic Initiatives
10.8. Chaitanya Biologicals Pvt. Ltd.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Portfolio
10.8.4. Strategic Initiatives
10.9. Tianjin Baofeng Chemical Co., Ltd.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Portfolio
10.9.4. Strategic Initiatives
10.10. Hangzhou Dakang New Materials Co., Ltd.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Portfolio
10.10.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/88k73w

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

These press releases may also interest you

at 22:56
Chinese leading biopharmaceutical company 3SBio (01530.HK) today announced its 2022 annual results. In 2022, 3SBio's core biopharmaceutical products posted robust growth, hair health business achieved blistering performance, and contract development...

at 21:45
The "Global Cell Dissociation Market by Product (Trypsin, Papain, DNase, Hyaluronidase, Instruments), Tissue Type (Connective Tissue, Epithelial Tissue), End-user (Pharma, Biopharma, Research Institutes) & Region - Forecast to 2028" report has been...

at 21:00
The "Global Medical Tubing Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Material, Structure, Application, End-User, and Major Regions" report has been added to  ResearchAndMarkets.com's offering. According to this analysis, the...

at 21:00
Asia Pacific Medical Technology Association (APACMed), the region's leading organization for medical technology manufacturers, has named  EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry and a market...

at 20:45
The "Global Hospital Furniture Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type, Manufacturing Material, Application, End User, Region" report has been added to  ResearchAndMarkets.com's offering. According to this...

at 20:25
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the pricing of an underwritten public...

News published on 31 january 2023 at 14:10 and distributed by: